The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
In a recent study, researchers compared the rates of screening and sensitivity of universal vs risk-based screening for hepatitis C virus in pregnant women.
The Affordable Care Act aimed to expand Medicaid access in an effort to bring health care to the uninsured. But how did it affect liver transplantation waitlists and the minorities at high risk? A new study...
Successful treatment of hepatitis C virus infection with direct-acting antivirals reduces the risk of cardiovascular events, according to the results of a recent study.
Liver fibrosis stage is an important factor in determining HCC risk. With this in mind, researchers aimed to evaluate the utility of liver stiffness in predicting HCC risk throughout the clinical course of...
A new survey of AAFP-affiliated family physicians explored attitudes, knowledge, and adoption of HCV screening recommendations. The results were shared at the American Public Health Association 2018 Annual...
A new proof-of-concept trial aimed to evaluate the safety of transplanting HCV-infected donor hearts and treating HCV-negative recipients preemptively with DAAs. Preliminary findings were presented at the...
Although approximately 12% of baby boomers are thought to undergo hepatitis C screening, new findings presented at the APHA Annual Meeting & Expo suggest that this estimate may be misleading.
